MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
MCRB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Seres Therapeutics (MCRB) Ownership - Who owns Seres Therapeutics?

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
101 Cambridgepark Drive
Phone
+1 617 945-9626
Employees
66
Web
https://www.serestherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
63.91M
P/E Ratio
12.22
Total Cash
29.83M
Projected Growth
N/A
Total Debt
80.5M
Revenue
1.15M
Risk (Beta)
0.73
Dividend Yield
N/A
Total Cash/Share
3.08
Total Debt/Equity
N/A
Revenue/Share
0.13 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
MCRB
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for MCRB
A.I. Advisor
published General Information

General Information

a developer of novel treatments for diseases related to the human microbiome

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
101 Cambridgepark Drive
Phone
+1 617 945-9626
Employees
66
Web
https://www.serestherapeutics.com